Jianlou Niu

State Key Laboratory Of Macromolecular Drugs And Large Scale Preparation
Wenzhou, 325035, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Colonic epithelial-derived FGF1 drives intestinal stem cell commitment toward goblet cells to suppress inflammatory bowel disease.

Colonic epithelial-derived FGF1 drives intestinal stem cell commitment toward goblet cells to suppress inflammatory bowel disease.

Journal: Nature communications

Published: October 11, 2024

FGF2 Mediated USP42-PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration.

FGF2 Mediated USP42-PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 28, 2024

Hepatocyte-Derived FGF1 Alleviates Isoniazid and Rifampicin-Induced Liver Injury by Regulating HNF4α-Mediated Bile Acids Synthesis.

Hepatocyte-Derived FGF1 Alleviates Isoniazid and Rifampicin-Induced Liver Injury by Regulating HNF4α-Mediated Bile Acids Synthesis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 27, 2024

FGF1ΔHBS ameliorates retinal inflammation via suppressing TSPO signal in a type 2 diabetes mouse model.

FGF1ΔHBS ameliorates retinal inflammation via suppressing TSPO signal in a type 2 diabetes mouse model.

Journal: Biochemical pharmacology

Published: September 15, 2023

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies.

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies.

Journal: Journal of visualized experiments : JoVE

Published: July 17, 2023

Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway.

Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: July 05, 2023

Acceptor engineering-facilitated versatile AIEgen for mitochondria-targeted multimodal imaging-guided cancer photoimmunotherapy.

Acceptor engineering-facilitated versatile AIEgen for mitochondria-targeted multimodal imaging-guided cancer photoimmunotherapy.

Journal: Biomaterials

Published: May 10, 2023

Engineered FGF19ΔKLB protects against intrahepatic cholestatic liver injury in ANIT-induced and Mdr2-/- mice model.

Engineered FGF19ΔKLB protects against intrahepatic cholestatic liver injury in ANIT-induced and Mdr2-/- mice model.

Journal: BMC biotechnology

Published: February 10, 2023

A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity.

A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity.

Journal: Redox biology

Published: October 24, 2021

Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects.

Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects.

Journal: Nature communications

Published: January 03, 2021

Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.

Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 04, 2020

Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4.

Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4.

Journal: Cell metabolism

Published: October 28, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026